Cardiovascular medicines: comparative costs and benefits

• In: Posters
• At: Dublin (Ireland) (2013)
• Type: Poster
• By: CARDONA, Mark (University of Malta, Pharmacy, Attard, Malta)
• Co-author(s): Serracino-Inglott, Anthony (University of Malta, Attard, Malta)
  Zarb Adami, Maurice (University of Malta, Attard, Malta)
  Azzopardi, Lilian (University of Malta, Attard, Malta)
  Vella, John (University of Malta, Attard, Malta)
  
• Abstract:

  
  Background
  : Cardiovascular disease (CVD) is the leading cause of death globally, accounting for an estimated 17.3 million people in 2008 and equating to a global cost of €863 million in 2010. This objectives of this study were to undertake a price comparison of originator and generic variants for CVD drugs and the estimate the cost to
  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login